8 electrical-engineering Fellowship positions at Center for Drug Evaluation and Research (CDER)

FDA Postdoctoral Glyco-technology Lab Fellowship

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available within the Food and Drug Administration (FDA) in The Center for Drug Evaluation and Research (CDER), The Office of Pharmaceutical Quality Research (OPQR), Office of Pharmaceutical...

FDA Fellowship in Comparative Gaps Analysis in Sickle Cell Disease

developing new therapies meeting unmet needs of patients with Sickle Cell Disease (SCD) have been challenging due to large gaps in our current understanding of the natural course of the disease and its

FDA Advanced Characterization of Biologics Lab Fellowship

Flow Imaging technology as well as screen the protein drug products for aggregation using high throughput dynamic light scattering. Appointment Length: The appointment will initially be for one year, but

Applying Large Language Models (LLM) in Drug Safety Reviews Fellowship

to generate testing datasets for LLM evaluation. Research the prompt engineering techniques and LLM performance metrics. The performance of LLMs will be analyzed against the gold standards generated by FDA

FDA Fellowship in Program, Policy and Operational Analysis

proposed and current CDER programs and policies by conducting quantitative and qualitative analyses to address operational needs. OPSA assesses the impact and efficiency of CDER initiatives and programs

Clinical Pharmacology of Therapeutic Biologics and Biosimilars Fellowship

developing recommendations for clinical pharmacology study design delineated by product groups which will be more advantageous when compared to the current product-by-product approach. This research projects

FDA Pharmacovigilance Fellowship: Methodological Assessment of Causal Associations

to multiple fields and disciplines. 3. Contribute to current knowledge in this field by presenting findings at conferences and/or publishing scientific manuscripts. Appointment Length: The appointment will

FDA Antimicrobial Pharmacology and Toxicology Fellowship

existing nonclinical safety data of monoclonal antibodies directed against microbial targets and use this information to further enhance (or improve upon) the current toxicology approach to predict safety